U.S. Market Expansion

Genflow Biosciences appoints seasoned biotech leader Gad Berdugo as Chairman to accelerate its gene therapy pipeline for age-related diseases. Berdugo’s expertise in RNA-LNP therapeutics and U.S. market expansion is expected to drive strategic growth. Key data readouts in 2026 will be critical under his guidance, with Tamara Joseph continuing on the board for continuity.